Page last updated: 2024-08-25

nedaplatin and Diarrhea

nedaplatin has been researched along with Diarrhea in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Chen, Z; Jiang, Y; Song, B1
Sun, F; Wang, J; Wu, X; Yang, CS; Zhang, J1
Furuta, I; Kurashina, K; Kurita, H; Miyata, M; Nozaki, S; Wada, S; Yamamoto, E1
Li, T; Yu, CH; Zhu, WG1
Ke, QH; Liu, Z; Su, XY; Yang, JY; Zhang, WT; Zhou, SQ1
Fujitani, K; Hirao, M; Tsujinaka, T1
Hashimoto, N; Kamiura, S; Kobayashi, K; Ohira, H; Saji, F; Samejima, Y; Sawai, K; Seino, H1

Trials

4 trial(s) available for nedaplatin and Diarrhea

ArticleYear
Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.
    Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:3

    Topics: Adult; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diarrhea; Docetaxel; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Neutropenia; Organoplatinum Compounds; Prospective Studies; Taxoids; Treatment Outcome; Young Adult

2010
[Analysis of the initial efficacy of nedaplatin combined with megestrol in concurrent chemoradiotherapy for advanced cervical cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:8

    Topics: Adenocarcinoma; Adult; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Diarrhea; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Leukopenia; Megestrol; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Particle Accelerators; Radiotherapy, High-Energy; Remission Induction; Survival Rate; Thrombocytopenia; Uterine Cervical Neoplasms

2011
Phase I study of the combination of nedaplatin, adriamycin and 5-fluorouracil for treatment of advanced esophageal cancer.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2004, Volume: 17, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diarrhea; Doxorubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Platelet Count; Treatment Outcome

2004
[Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diarrhea; Drug Administration Schedule; Female; Humans; Hysterectomy; Infusions, Intravenous; Middle Aged; Nausea; Neoadjuvant Therapy; Organoplatinum Compounds; Radiotherapy, Adjuvant; Uterine Cervical Neoplasms; Vomiting, Anticipatory

2001

Other Studies

3 other study(ies) available for nedaplatin and Diarrhea

ArticleYear
Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
    Computational and mathematical methods in medicine, 2022, Volume: 2022

    Topics: Abdominal Pain; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Case-Control Studies; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Exanthema; Female; Humans; Hyperglycemia; Irinotecan; Nausea; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms; Vomiting

2022
Selenium nanoparticles act as an intestinal p53 inhibitor mitigating chemotherapy-induced diarrhea in mice.
    Pharmacological research, 2019, Volume: 149

    Topics: Animals; Antineoplastic Agents; Diarrhea; Male; Mice; Nanoparticles; Organoplatinum Compounds; Protective Agents; Selenium; Thrombospondin 1; Tumor Suppressor Protein p53

2019
[Dose escalation of domestic nedaplatin used in concurrent chemoradiotherapy for cervical cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Radiotherapy, Conformal; Thrombocytopenia; Uterine Cervical Neoplasms; Vomiting

2011